Partnering in oncogenetic research - The INHERIT BRCAs experience: opportunities and challenges

Familial Cancer

Volumn 5, Issue 1, 2006, Pages 3-13

  Avard, Denise ^a   Bridge, Peter ^b   Bucci, Lucie M ^a   Chiquette, Jocelyne ^c   Dorval, Michel ^c   Durocher, Francine ^c   Easton, Doug ^d   Godard, Béatrice ^a   Goldgar, David ^e   Knoppers, Bartha Maria ^a,f   Laframboise, Rachel ^g   Lespérance, Bernard ^h   Plante, Marie ^c   Tavtigian, Sean V ^e   Vézina, Hélène ⁱ   Wilson, Brenda ^j   Simard, Jacques ^c,f  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f World Health Organization ^*

^g UNIVERSITÉ LAVAL   (Canada)

^h HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

ⁱ UNIVERSITÉ DU QUÉBEC À CHICOUTIMI   (Canada)

^j UNIVERSITY OF OTTAWA   (Canada)

more..

Author keywords

Academic teams; Clinical practice; Collaboration; Familial cancer; Genetics; Hereditary cancer; Interdisciplinary; Knowledge translation; Research

Indexed keywords

ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RESEARCH; CANCER SUSCEPTIBILITY; EVIDENCE BASED MEDICINE; GENE LOCUS; GENE MUTATION; HEALTH BEHAVIOR; MISSENSE MUTATION; ONCOGENE; PRIORITY JOURNAL; QUALITY OF LIFE; WORLD HEALTH ORGANIZATION;

BREAST NEOPLASMS; CANADA; FEMALE; FORECASTING; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC RESEARCH; GENETIC SCREENING; HUMANS; INCIDENCE; INTERPROFESSIONAL RELATIONS; NEOPLASTIC SYNDROMES, HEREDITARY; PROGNOSIS; RISK ASSESSMENT;

EID: 33644893093     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-005-2570-8     Document Type: Article

References (72)

1. D Ford DF Easton M Stratton 1998 Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 62 3 676 89
2. Department of Health 2003 Genetics White Paper: Our Inheritance, Our Future - Realising the Potential of Genetics in the National Health System Department of Health London, UK
3. MJ Khoury W Burke EJ Thomson 2000 Genetics and Public Health in the 21st Century. Using Genetic Information to Improve Health and Prevent Disease Oxford University Press Oxford
4. MJ Khoury J Little W Burke 2004 Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease Oxford University Press Oxford
5. SM Lippman B Levin DE Brenner 2004 Cancer prevention and the American Society of Clinical Oncology J Clin Oncol 22 19 3848 51
6. AE Guttmacher FS Collins RH Carmona 2004 The family history - more important than ever N Engl J Med 351 22 2333 6
7. K Hemminki C Eng 2004 Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans J Med Genet 41 11 801 7
8. KL Nathanson R Wooster BL Weber 2001 Breast cancer genetics: What we know and what we need Nat Med 7 5 552 6
9. BA Ponder 2001 Cancer genetics Nature 411 6835 336 41
10. AR Horwitz 2003 Building bridges through collaboration - a pathway for interdisciplinary research Trends Cell Biol 13 1 2 3
11. GC O'Connor MP Rice L Peters JG Veryzer 2003 Managing interdisciplinary, longitudinal research teams: Extending grounded theory-building methodologies Org Sci 14 4 353 73
12. JT Klein 1990 Interdisciplinarity: History, Theory and Practice Wayne State University Press Detroit, MI
13. J Qin FW Lancaster B Allen 1997 Types and levels of collaboration in interdisciplinary research in the sciences Journal of the American Society for Information Science 48 10 893 916
14. N Metzger RN Zare 1999 Interdisciplinary research: From belief to reality Science 283 5402 642 3
15. JS Altshuler D Altshuler 2004 Organizational challenges in clinical genomic research Nature 429 6990 478 81
16. J Lomas 2000 Connecting research and policy Can J Policy Res 1 140 4
17. C Lenfant 2003 Shattuck lecture - clinical research to clinical practice - lost in translation? N Engl J Med 349 9 868 74
18. A Forbes P Griffiths 2002 Methodological strategies for the identification and synthesis of 'evidence' to support decision-making in relation to complex healthcare systems and practices Nurs Inq 9 3 141 55
19. B Vogelstein KW Kinzler 2004 Cancer genes and the pathways they control Nat Med 10 8 789 99
20. PD Pharoah A Antoniou M Bobrow 2002 Polygenic susceptibility to breast cancer and implications for prevention Nat Genet 31 1 33 6
21. PD Pharoah AM Dunning BA Ponder DF Easton 2004 Association studies for finding cancer-susceptibility genetic variants Nat Rev Cancer 4 11 850 60
22. SA Narod 2002 Modifiers of risk of hereditary breast and ovarian cancer Nat Rev Cancer 2 2 113 23
23. H Jernstrom J Lubinski HT Lynch 2004 Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers J Natl Cancer Inst 96 14 1094 8
24. AC Antoniou DF Easton 2003 Polygenic inheritance of breast cancer: Implications for design of association studies Genet Epidemiol 25 3 190 202
25. Smith P, Spurdle A, Harrington PA et al. Analysis of polymorphisms in DNA repair genes as modifiers of breast cancer risk in BRCA1 and BRCA2 carriers. The American Society of Human Genetics, 54th Annual Meeting, October 26-30, 2004, Toronto, Ontario, Canada. Abstract #438, p. 100.
26. Simard J, Dumont M, Moisan A-M et al. Molecular epidemiology of BRCA1 and BRCA2 mutations in French Canadian breast/ovarian families. The American Society of Human Genetics, 54th Annual Meeting, October 26-30, 2004, Toronto, Ontario, Canada. Abstract #480, p. 107.
27. D Goldgar D Easton A Deffenbaugh 2004 Integrated evaluation of DNA sequence variants of unknown clinical significance: Application to BRCA1 and BRCA2 Am J Hum Genet 75 535 44
28. OM Serova S Mazoyer N Puget 1997 Mutations in BRCA1 and BRCA2 in breast cancer families: Are there more breast cancer-susceptibility genes? Am J Hum Genet 60 3 486 95
29. AC Antoniou DF Easton 2003 Polygenic inheritance of breast cancer: Implications for design of association studies Genet Epidemiol 25 3 190 202
30. D Thompson JS Witte M Slattery D Goldgar 2004 Increased power for case-control studies of single nucleotide polymorphisms through incorporation of family history and genetic constraints Genet Epidemiol 27 3 215 24
31. CR Scriver 2001 Human genetics: Lessons from Quebec populations Annu Rev Genom Hum Genet 2 69 101
32. H Vézina F Durocher M Dumont L Houde 2005 Molecular and Genealogical Characterization of the R1443X-BRCA1 Mutation in High-risk French-Canadian Breast/Ovarian Cancer Families Hum Genet 117 (2-3) 119 132
33. E [tmp] McNally A Cambon-Thomsen 2004 Ethical, Legal and Social Aspects of Genetic Testing: Research, Development and Clinical Applications European Commission Brussels
34. Z Einbeigi A Bergman P Karlsson 2003 Population study on BRCA1/2 mutations in women with breast and ovarian cancer in western Sweden Breast 12 S1 S17
35. R Inoue T Ushijima T Fukutomi 1997 BRCA2 germline mutations in Japanese breast cancer families Int J Cancer 74 2 199 204
36. DM Eccles 2003 Genetic testing for BRCA1 mutation in the UK Lancet 361 9352 178 9
37. W Burke M Daly J Garber 1997 Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium JAMA 277 12 997 1003
38. Noorani HZ, McGahan L. Predictive Genetic Testing for Breast and Prostate Cancer. Ottawa, Canada: Canadian Coordinating Office for Health and Technology Assessment (CCOHTA) 1999; Report No. 4.
39. Goldgar D, Bonnardel C, Renard H, Yaqoubi O. The International BRCA1/2 Carrier Cohort Study: Purpose, Rationale and study design. Breast Cancer Res 2000; 2: e010.
40. A Baum AL Friedman SG Zakowski 1997 Stress and genetic testing for disease risk Health Psychol 16 1 8 19
41. M Dorval E Maunsell MJ Dugas J Simard 2001 Support groups for people carrying a BRCA mutation CMAJ 165 6 740
42. Dorval M, Maunsell E, Patenaude AF et al. Elapsed time to disclosure of BRCA1/2 genetic testing result and participants' distress: Preliminary finding from a research setting. Psycho-Oncology 2000; 9(5 Suppl) abstract #341.
43. Dorval M, Gauthier G, Maunsell E et al. Are women with an inconclusive BRCA1/2 genetic tests result falsely reassured? Psycho-Oncology 2003; 124(4 Suppl).
44. M Dorval S Morel E Maunsell 2003 When using the Impact of Events Scale to assess psychological distress in the context of BRCA1/2 testing, does the event matter? Psycho-Oncology 12 4 Suppl 307
45. Dorval M, Davilmar A, Rouleau I et al. Men undergoing BRCA1/2 genetic testing: Who are they and why do they do it? Psycho-Oncology 2005; 14(s85).
46. I Rouleau J Chiquette M Plante 2004 Changes in health-related behaviours following BRCA 1/2 genetic testing: The case of hormone replacement therapy J Obstet Gynaecol Can 26 12 1059 66
47. MH Vallee I Rouleau M Plante 2005 Hormone therapy use among women tested for BRCA1/2 mutations following the publication of the Women's Health Initiative Study results J Obstet Gynaecol Can 27 4 321
48. BJ Wilson K Forrest ER Teijlingen 2004 Family communication about genetic risk: The little that is known Genetics 7 15 24
49. T Lemmens Y Joly BM Knoppers 2004 Genetics and life insurance: A comparative approach GenEdit 2 2 1 15
50. EW Clayton 2004 Policy challenges ethical, legal, and social implications of genetics Magill Genetic and Ethics An Interdisciplinary Study Saint Louis University Press Saint Louis 23 34
51. World Health Organization 1997 Statement of WHO Expert Advisory Group on Ethical Issues in Medical Genetics WHO Geneva
52. BM Knoppers Y Joly 2004 Physicians, genetics and life insurance CMAJ 170 9 1421 3
53. L Skene 1998 Patients' rights or family responsibilities? Two approaches to genetic testing Med Law Rev 6 1 1 41
54. M Letendre B Godard 2004 Expanding the physician's duty of care: A duty to recontact? Med Law 23 3 531 9
55. JL Benkendorf JE Reutenauer CA Hughes 1997 Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility Am J Med Genet 73 3 296 303
56. J Birdsell J Atkinson-Grosjean R Landry 2002 Knowledge Translation in Two New Programs: Achieving the 'Pasteur Effect' Canadian Institutes of Health Research Ottawa
57. C Shaw A [tmp] McIntosh G Evans 2004 Clinical Guidelines and Evidence Review for the Classification and Care of Women at Risk of Familial Breast Cancer National Collaborating Centre for Primary Care/University of Sheffield London
58. F Eisinger B Bressac D Castaigne 2004 Identification and management of hereditary predisposition to cancer of the breast and the ovary - update 2004 Bull Cancer 91 3 219 37
59. JM Grimshaw RE Thomas G [tmp] MacLennan 2004 Effectiveness and efficiency of guideline dissemination and implementation strategies Health Technol Assess 8 6 iii 72
60. DR Carlow 2000 Status report: Canadian association of provincial cancer agencies Chronic Diseases Canada 21 1 30 3
61. HF Vasen NE Haites DG Evans 1998 Current policies for surveillance and management in women at risk of breast and ovarian cancer: A survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group Eur J Cancer 34 12 1922 6
62. World Health Organization 1997 Proposed International Guidelines on Ethical Issues in Medical Genetics and Genetic Service. Report of a WHO Meeting on Ethical Issues in Medical Genetics World Health Organization Geneva
63. World Health Organization. Control of Hereditary Diseases. Geneva: WHO 1996; Report No. 865.
64. J Emery A Lucassen M Murphy 2001 Common hereditary cancers and implications for primary care Lancet 358 9275 56 63
65. The New York State Task Force on Life and the Law 2000 Integrating Genetic Services into Clinical Care. Genetic Testing and Screening in the Age of Genomic Medicine The New York State Task Force on Life and the Law New York 347 86
66. C Bayley 2004 The challenge of physician education in genetics G Magill Genetics and Ethics: An Interdisciplinary Study Saint Louis University Press Saint Louis 176 85
67. GEOQ. Goupe d'Etude en Oncologie du Quebec 2005. Ref Type: Internet Communication.
68. PW Yoon MT Scheuner MJ Khoury 2003 Research priorities for evaluating family history in the prevention of common chronic diseases Am J Prev Med 24 2 128 35
69. A Antoniou PD Pharoah S Narod 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: A combined analysis of 22 studies Am J Hum Genet 72 5 1117 30
70. DE Goldgar DF Easton AM Deffenbaugh 2004 Integrated evaluation of DNA sequence variants of unknown clinical significance: Application to BRCA1 and BRCA2 Am J Hum Genet 75 4 535 44
71. AC Antoniou DF Easton 2003 Polygenic inheritance of breast cancer: Implications for design of association studies Genet Epidemiol 25 3 190 202
72. CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 2004; 74(6): 1175-82.